Headache research in 2020: disrupting and improving practice
-
Published:2021-01
Issue:1
Volume:20
Page:7-8
-
ISSN:1474-4422
-
Container-title:The Lancet Neurology
-
language:en
-
Short-container-title:The Lancet Neurology
Subject
Clinical Neurology
Reference10 articles.
1. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial;Mulleners;Lancet Neurol,2020
2. Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial;Goadsby;Lancet Neurol,2020
3. Central effects of erenumab in migraine patients: an event-related functional imaging study;Ziegeler;Neurology,2020
4. Lasmiditan for the acute treatment of migraine: subgroup analyses by prior response to triptans;Knievel;Cephalalgia,2020
5. Spectrum of headaches associated with SARS-CoV-2 infection: study of healthcare professionals;Porta-Etessam;Headache,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献